First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance

Masoud Shamaei, Majid Marjani, Ehsan Chitsaz, Mehdi Kazempour, Mehdi Esmaeili, Parisa Farnia, Payam Tabarsi, Majid V. Amiri, Mehdi Mirsaeidi, Davood Mansouri, Mohammad R. Masjedi, Ali A. Velayati

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objective: Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and alarming threat in most regions worldwide. Methods: This was a descriptive cross-sectional study at a tertiary hospital in Iran, using patient medical records for 2000-2003. The findings were analyzed following the same framework as that used for previous reports from this center. Results: Among 1556 TB patients, drug susceptibility testing (DST) was performed for 548 culture-positive cases. Anti-TB drug resistance to both isoniazid and rifampin was identified in 10 (2.8%) of the new TB cases (multidrug-resistant TB; MDR-TB). Any resistance was detected in 228 (41.6%), showing an increasing trend in both new and retreatment cases. The data analysis revealed that drug-resistant TB had a statistically significant association with Afghan ethnicity, age >65 years, and the type of disease (retreatment vs. new TB case) (p <0.05). Also, assessment of the drug resistance trends showed a significant increase in resistance to any anti-TB agent, to isoniazid, and to streptomycin in new cases, and to all of the first-line anti-TB drugs in retreatment patients. Conclusions: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases. Hence, revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey, are recommended.

Original languageEnglish (US)
JournalInternational Journal of Infectious Diseases
Volume13
Issue number5
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Retreatment
Iran
Drug Resistance
Tuberculosis
Referral and Consultation
Isoniazid
Pharmaceutical Preparations
Streptomycin
Rifampin
Tertiary Care Centers
Medical Records
Cross-Sectional Studies

Keywords

  • Drug resistance
  • Iran
  • Trends
  • Tuberculosis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance. / Shamaei, Masoud; Marjani, Majid; Chitsaz, Ehsan; Kazempour, Mehdi; Esmaeili, Mehdi; Farnia, Parisa; Tabarsi, Payam; Amiri, Majid V.; Mirsaeidi, Mehdi; Mansouri, Davood; Masjedi, Mohammad R.; Velayati, Ali A.

In: International Journal of Infectious Diseases, Vol. 13, No. 5, 09.2009.

Research output: Contribution to journalArticle

Shamaei, M, Marjani, M, Chitsaz, E, Kazempour, M, Esmaeili, M, Farnia, P, Tabarsi, P, Amiri, MV, Mirsaeidi, M, Mansouri, D, Masjedi, MR & Velayati, AA 2009, 'First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance', International Journal of Infectious Diseases, vol. 13, no. 5. https://doi.org/10.1016/j.ijid.2008.11.027
Shamaei, Masoud ; Marjani, Majid ; Chitsaz, Ehsan ; Kazempour, Mehdi ; Esmaeili, Mehdi ; Farnia, Parisa ; Tabarsi, Payam ; Amiri, Majid V. ; Mirsaeidi, Mehdi ; Mansouri, Davood ; Masjedi, Mohammad R. ; Velayati, Ali A. / First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance. In: International Journal of Infectious Diseases. 2009 ; Vol. 13, No. 5.
@article{1f0a7ff567bc4d4b8e0eae94a226c44a,
title = "First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance",
abstract = "Objective: Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and alarming threat in most regions worldwide. Methods: This was a descriptive cross-sectional study at a tertiary hospital in Iran, using patient medical records for 2000-2003. The findings were analyzed following the same framework as that used for previous reports from this center. Results: Among 1556 TB patients, drug susceptibility testing (DST) was performed for 548 culture-positive cases. Anti-TB drug resistance to both isoniazid and rifampin was identified in 10 (2.8{\%}) of the new TB cases (multidrug-resistant TB; MDR-TB). Any resistance was detected in 228 (41.6{\%}), showing an increasing trend in both new and retreatment cases. The data analysis revealed that drug-resistant TB had a statistically significant association with Afghan ethnicity, age >65 years, and the type of disease (retreatment vs. new TB case) (p <0.05). Also, assessment of the drug resistance trends showed a significant increase in resistance to any anti-TB agent, to isoniazid, and to streptomycin in new cases, and to all of the first-line anti-TB drugs in retreatment patients. Conclusions: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases. Hence, revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey, are recommended.",
keywords = "Drug resistance, Iran, Trends, Tuberculosis",
author = "Masoud Shamaei and Majid Marjani and Ehsan Chitsaz and Mehdi Kazempour and Mehdi Esmaeili and Parisa Farnia and Payam Tabarsi and Amiri, {Majid V.} and Mehdi Mirsaeidi and Davood Mansouri and Masjedi, {Mohammad R.} and Velayati, {Ali A.}",
year = "2009",
month = "9",
doi = "10.1016/j.ijid.2008.11.027",
language = "English (US)",
volume = "13",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran-eight years of surveillance

AU - Shamaei, Masoud

AU - Marjani, Majid

AU - Chitsaz, Ehsan

AU - Kazempour, Mehdi

AU - Esmaeili, Mehdi

AU - Farnia, Parisa

AU - Tabarsi, Payam

AU - Amiri, Majid V.

AU - Mirsaeidi, Mehdi

AU - Mansouri, Davood

AU - Masjedi, Mohammad R.

AU - Velayati, Ali A.

PY - 2009/9

Y1 - 2009/9

N2 - Objective: Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and alarming threat in most regions worldwide. Methods: This was a descriptive cross-sectional study at a tertiary hospital in Iran, using patient medical records for 2000-2003. The findings were analyzed following the same framework as that used for previous reports from this center. Results: Among 1556 TB patients, drug susceptibility testing (DST) was performed for 548 culture-positive cases. Anti-TB drug resistance to both isoniazid and rifampin was identified in 10 (2.8%) of the new TB cases (multidrug-resistant TB; MDR-TB). Any resistance was detected in 228 (41.6%), showing an increasing trend in both new and retreatment cases. The data analysis revealed that drug-resistant TB had a statistically significant association with Afghan ethnicity, age >65 years, and the type of disease (retreatment vs. new TB case) (p <0.05). Also, assessment of the drug resistance trends showed a significant increase in resistance to any anti-TB agent, to isoniazid, and to streptomycin in new cases, and to all of the first-line anti-TB drugs in retreatment patients. Conclusions: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases. Hence, revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey, are recommended.

AB - Objective: Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and alarming threat in most regions worldwide. Methods: This was a descriptive cross-sectional study at a tertiary hospital in Iran, using patient medical records for 2000-2003. The findings were analyzed following the same framework as that used for previous reports from this center. Results: Among 1556 TB patients, drug susceptibility testing (DST) was performed for 548 culture-positive cases. Anti-TB drug resistance to both isoniazid and rifampin was identified in 10 (2.8%) of the new TB cases (multidrug-resistant TB; MDR-TB). Any resistance was detected in 228 (41.6%), showing an increasing trend in both new and retreatment cases. The data analysis revealed that drug-resistant TB had a statistically significant association with Afghan ethnicity, age >65 years, and the type of disease (retreatment vs. new TB case) (p <0.05). Also, assessment of the drug resistance trends showed a significant increase in resistance to any anti-TB agent, to isoniazid, and to streptomycin in new cases, and to all of the first-line anti-TB drugs in retreatment patients. Conclusions: There has been an increasing trend in drug resistance in recent years, particularly in retreatment cases. Hence, revision of the national TB control program, reevaluation of the role of the World Health Organization category II (CAT II) regimen, as well as the conducting of a nationwide drug resistance survey, are recommended.

KW - Drug resistance

KW - Iran

KW - Trends

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=69249245345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249245345&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2008.11.027

DO - 10.1016/j.ijid.2008.11.027

M3 - Article

VL - 13

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 5

ER -